ArticleMolecular carcinogenesis2022

Setting up clinical trials for success: Applying preclinical advances in combined TGFβ/PD-L1 inhibition to ongoing clinical studies.

Alexander A Strait et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.